Entrada Therapeutics, Inc. · NASDAQ:TRDA
MPM BioVentures 2018 LLC sold 86,914 Entrada Therapeutics, Inc. shares (Form 4)
Traded Aug 27 to Aug 31, 2026 · Filed Aug 31, 2026
From Aug 27 to Aug 31, 2026, MPM BioVentures 2018 LLC (10% owner) sold 86,914 Entrada Therapeutics, Inc. shares at an average US$7.08 for US$616K, leaving 4,231,434 shares. Filed Aug 31, 2026 (Form 4).
- Sold
- 86,914 shares
- Price
- US$7.08 average (US$6.99 to US$7.20)
- Value
- US$616K
- Holding after
- 4,231,434 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 27, 2026 | Common Stock | Sale | 38,922 | US$7.20 | 4,279,426 | Indirect |
| Aug 28, 2026 | Common Stock | Sale | 3,733 | US$7.01 | 4,275,693 | Indirect |
| Aug 31, 2026 | Common Stock | Sale | 44,259 | US$6.99 | 4,231,434 | Indirect |
Source
Related
- Entrada Therapeutics, Inc.
- MPM BioVentures 2018 LLC
- Entrada Therapeutics, Inc. shareholders
- Form 4 · MPM BioVentures 2018 LLC · Sep 3, 2026
- Form 4 · MPM BioVentures 2018 LLC · Aug 26, 2026
- Schedule 13D/A · Ansbert Gadicke · Sep 10, 2026
- Form 4 · MPM BioVentures 2018 GP LLC · Sep 9, 2026
- Form 4 · Mpm Bioventures 2018 (B), L.P. · Sep 9, 2026
- Form 4 · MPM BioVentures 2014 GP LLC · Sep 3, 2026
- Form 4 · Dowden Nathan J · Sep 3, 2026